![William F. Hahne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of William F. Hahne
Former positions of William F. Hahne
Companies | Position | Start | End |
---|---|---|---|
IMUNON, INC. | Chief Tech/Sci/R&D Officer | 2005-12-31 | 2007-11-30 |
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 2002-12-31 | 2004-12-31 |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Chief Tech/Sci/R&D Officer | 1996-12-31 | 2001-12-31 |
BIO-PATH HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2017-04-16 | - |
Corporate Officer/Principal | - | - | |
Vion Pharmaceuticals, Inc.
![]() Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Chief Tech/Sci/R&D Officer | 2008-01-31 | - |
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | - | - |
Training of William F. Hahne
Cornell University | Doctorate Degree |
Grinnell College | Undergraduate Degree |
Statistics
International
United States | 8 |
Operational
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
IMUNON, INC. | Health Technology |
BIO-PATH HOLDINGS, INC. | Health Technology |
Private companies | 3 |
---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Vion Pharmaceuticals, Inc.
![]() Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Stock Market
- Insiders
- William F. Hahne
- Experience